124 related articles for article (PubMed ID: 38215027)
1. Ruthenium Pyrazole Complexes: A Family of Highly Active Metallodrugs for Photoactivated Chemotherapy.
Hirahara M; Iwamoto A; Teraoka Y; Mizuno Y; Umemura Y; Uekita T
Inorg Chem; 2024 Jan; 63(4):1988-1996. PubMed ID: 38215027
[TBL] [Abstract][Full Text] [Related]
2. Intramolecular Hydrogen Bonding: A Key Factor Controlling the Photosubstitution of Ruthenium Complexes.
Hirahara M; Nakano H; Uchida K; Yamamoto R; Umemura Y
Inorg Chem; 2020 Aug; 59(16):11273-11286. PubMed ID: 32799483
[TBL] [Abstract][Full Text] [Related]
3. A Synthetic Route to a Ruthenium Complex via Successive Photosubstitution Reactions.
Hirahara M; Umemura Y
Inorg Chem; 2021 Sep; 60(17):13193-13199. PubMed ID: 34492768
[TBL] [Abstract][Full Text] [Related]
4. Preparation, stability, and photoreactivity of thiolato ruthenium polypyridyl complexes: Can cysteine derivatives protect ruthenium-based anticancer complexes?
van Rixel VH; Busemann A; Göttle AJ; Bonnet S
J Inorg Biochem; 2015 Sep; 150():174-81. PubMed ID: 26187140
[TBL] [Abstract][Full Text] [Related]
5. New Ru(II) complexes for dual photoreactivity: ligand exchange and (1)O2 generation.
Knoll JD; Albani BA; Turro C
Acc Chem Res; 2015 Aug; 48(8):2280-7. PubMed ID: 26186416
[TBL] [Abstract][Full Text] [Related]
6. Ru(II) Polypyridyl Complexes Derived from Tetradentate Ancillary Ligands for Effective Photocaging.
Li A; Turro C; Kodanko JJ
Acc Chem Res; 2018 Jun; 51(6):1415-1421. PubMed ID: 29870227
[TBL] [Abstract][Full Text] [Related]
7. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
[TBL] [Abstract][Full Text] [Related]
8. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release.
Hufziger KT; Thowfeik FS; Charboneau DJ; Nieto I; Dougherty WG; Kassel WS; Dudley TJ; Merino EJ; Papish ET; Paul JJ
J Inorg Biochem; 2014 Jan; 130():103-11. PubMed ID: 24184694
[TBL] [Abstract][Full Text] [Related]
10. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
Fayad C; Audi H; Khnayzer RS; Daher CF
J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
[TBL] [Abstract][Full Text] [Related]
11. Mononuclear and Binuclear Ruthenium(II) Complexes Containing 2,2'-Bipyridine or 1,10-Phenanthroline and Pyrazole-3,5-Bis(benzimidazole). Synthesis, Structure, Isomerism, Spectroscopy, and Proton-Coupled Redox Activity.
Baitalik S; Flörke U; Nag K
Inorg Chem; 1999 Jul; 38(14):3296-3308. PubMed ID: 11671063
[TBL] [Abstract][Full Text] [Related]
12. The remarkable reactivity of high oxidation state ruthenium and osmium polypyridyl complexes.
Meyer TJ; Huynh MH
Inorg Chem; 2003 Dec; 42(25):8140-60. PubMed ID: 14658865
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium Complexes with Protic Ligands: Influence of the Position of OH Groups and π Expansion on Luminescence and Photocytotoxicity.
Oladipupo OE; Prescott MC; Blevins ER; Gray JL; Cameron CG; Qu F; Ward NA; Pierce AL; Collinson ER; Hall JF; Park S; Kim Y; McFarland SA; Fedin I; Papish ET
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983054
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium Complexes are pH-Activated Metallo Prodrugs (pHAMPs) with Light-Triggered Selective Toxicity Toward Cancer Cells.
Qu F; Park S; Martinez K; Gray JL; Thowfeik FS; Lundeen JA; Kuhn AE; Charboneau DJ; Gerlach DL; Lockart MM; Law JA; Jernigan KL; Chambers N; Zeller M; Piro NA; Kassel WS; Schmehl RH; Paul JJ; Merino EJ; Kim Y; Papish ET
Inorg Chem; 2017 Jul; 56(13):7519-7532. PubMed ID: 28636344
[TBL] [Abstract][Full Text] [Related]
15. Bis(acetylacetonato)bis(pyrazolato)ruthenate(iii) as a redox-active scorpionate ligand.
Yoshida J; Sugawara K; Yuge H; Okabayashi J
Dalton Trans; 2014 Nov; 43(42):16066-73. PubMed ID: 25238163
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and intramolecular and interionic structural characterization of half-sandwich (arene)ruthenium(II) derivatives of bis(pyrazolyl)alkanes.
Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Di Nicola C; Macchioni A; Zuccaccia D; Monari M; Piccinelli F
Inorg Chem; 2008 Dec; 47(24):11593-603. PubMed ID: 18998632
[TBL] [Abstract][Full Text] [Related]
17. Pyrazole appended quinoline-BODIPY based arene ruthenium complexes: their anticancer activity and potential applications in cellular imaging.
Paitandi RP; Sharma V; Singh VD; Dwivedi BK; Mobin SM; Pandey DS
Dalton Trans; 2018 Dec; 47(48):17500-17514. PubMed ID: 30507985
[TBL] [Abstract][Full Text] [Related]
18. Quaternary Ru(II) complexes of terpyridines, saccharin and 1,2-azoles: effect of substituents on molecular structure, speciation, photoactivity, and photocytotoxicity.
Kumar P; Singh P; Saren S; Sayala J; Sivakumar S; Patra AK
Dalton Trans; 2022 Dec; 51(48):18416-18437. PubMed ID: 36416455
[TBL] [Abstract][Full Text] [Related]
19. Diastereoselective Synthesis and Two-Step Photocleavage of Ruthenium Polypyridyl Complexes Bearing a Bis(thioether) Ligand.
Meijer MS; Bonnet S
Inorg Chem; 2019 Sep; 58(17):11689-11698. PubMed ID: 31433170
[TBL] [Abstract][Full Text] [Related]
20. Factors that influence singlet oxygen formation vs. ligand substitution for light-activated ruthenium anticancer compounds.
Papish ET; Oladipupo OE
Curr Opin Chem Biol; 2022 Jun; 68():102143. PubMed ID: 35483128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
